Danish company Novo Nordisk's membership in a UK pharmaceutical industry body has been restored after a two-year suspension ...
Rafe Uddin So Starlink’s role in a number of European countries means that it’s seen as an easy target, given Musk’s proximity to Trump. There are also fears about a peace settlement between Russia ...
Building upon its already impressive obesity drug portfolio, Novo Nordisk A/S has licensed a triple agonist of the receptors for GLP-1, GIP and glucagon from United Biotechnology Co. Ltd. China-based ...
AstraZeneca said on Friday it will spend $2.5 billion on a research and development hub in Beijing, as the drugmaker ...
12d
European markets closed lower on Thursday, stumbling as President Donald Trump’s tariffs policy upends global trading ...
Pharma giant Novo Nordisk was among the top performers ... position to overcome domestic opposition when negotiating with Beijing, much like when former U.S. President Richard Nixon reestablished ...
Through the Task Force, AstraZeneca previously collaborated with Lonza, Novartis, Novo Nordisk and Roche to orchestrate the ... Guangdong, Shanghai and Beijing. “The combination of the original ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback